Eliminating hepatitis C: Part 3. Curing hepatitis C in general practice

Tara Purcell, Amanda Wade, Lisa Accadia, Simone Strasser, Phillip Read, Nicole Allard, David Baker, Alisa Pedrana, Joseph Doyle

Research output: Contribution to journalReview ArticleOtherpeer-review

2 Citations (Scopus)


Most patients with hepatitis C are treated with pangenotypic direct-acting antivirals (DAAs) such as sofosbuvir/velpatasvir and glecaprevir/pibrentasvir. GPs experienced in the management of hepatitis C can prescribe DAAs independently. Others must consult with a specialist before prescribing; online resources can streamline this process. Important considerations before prescribing include barriers to adherence and drug interactions.

Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalMedicine Today
Issue number8
Publication statusPublished - 2019

Cite this